Condition
Spondylitis, Ankylosing
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 13 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
13 shownEffects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory DiseasesNCT06842316 · 2025-04-10
RECRUITINGStudy of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory RheumatismNCT05961267 · 2023-07-24
COMPLETEDRecombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesNCT05879419 · 2023-05-23
ACTIVE_NOT_RECRUITINGSurvey About Diet in Chronic Inflammatory Rheumatic DiseasesNCT05283096 · 2022-02-10
UNKNOWNThe Relationship Between Inflammatory ARTritis and CArdiac DIseAseNCT05647577 · 2021-01-01
ACTIVE_NOT_RECRUITINGCharacterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.NCT04731831 · 2020-08-01
UNKNOWNOne-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyNCT03662919 · 2018-07-02
COMPLETEDA Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)NCT01313858 · 2010-04-01
COMPLETEDHeart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF BlockerNCT01072058 · 2008-02-01
UNKNOWNAn Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsNCT00760669 · 2007-05-01
COMPLETEDC.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in FranceNCT02886689 · 2007-01-01
COMPLETEDStudy Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisNCT00273858 · 2006-03-01
TERMINATEDPost Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)NCT00727298 · 2006-02-01
COMPLETEDCommon interventions
1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease)OTHER1AdalimumabDRUG1InfliximabBIOLOGICAL1InfliximabDRUG1Infliximab; observational studyDRUG1MethotrexateDRUG1Methotrexate; observational studyDRUG1MMF DiscontinuationOTHER1MMF maintainOTHER1MTX DiscontinuationOTHER1MTX maintainOTHER1PlaceboOTHER1QuestionnaireBEHAVIORAL1QuestionnaireOTHER1Recombinant Herpes Zoster Vaccine (RZV)BIOLOGICAL1Simponi®DRUG1There is no Intervention. The study is observational.OTHER1TNF blockers (infliximab, adalimumab, etanercept)DRUG1TNF-alpha antagonist and other biotherapyDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Merck Sharp & Dohme LLC
2
Aalborg University Hospital
1
Biogen
1
Central Hospital, Nancy, France
1
Centre Hospitalier Régional d'Orléans
1
Janssen Korea, Ltd., Korea
1
Poitiers University Hospital
1
University Hospital, Bordeaux
1
University Hospital, Gentofte, Copenhagen
1
University of Sao Paulo
1
University of Sao Paulo General Hospital
1
Wyeth is now a wholly owned subsidiary of Pfizer
1
Trial status mix
COMPLETED6
UNKNOWN3
ACTIVE_NOT_RECRUITING2
RECRUITING1
TERMINATED1
Phase mix
PHASE42
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.